Beta-endorphins in acute myocardial infarction.

Area of Science:

• Endocrinology
• Cardiology
• Pain Perception

Background:

• Endogenous peptide B-endorphin (B-EP) plays a role in homeostasis, behavior, and pain perception.
• Acute myocardial infarction (AMI) is a critical condition involving significant pain and stress.
• Understanding the relationship between B-EP and AMI markers is crucial for pain management.

Purpose of the Study:

• To investigate the correlation between plasma B-EP levels and pain intensity in AMI patients.
• To examine the relationship between B-EP and specific AMI biomarkers (enzymes and stress hormones).

Main Methods:

• Studied 26 AMI patients within 72 hours of symptom onset and 7 healthy controls.
• Collected blood samples for B-EP, AMI enzymes (AST, LDH, CPK), and stress hormones (cortisol, growth hormone) before opiate treatment.
• Utilized the Immunonuclear Corporation protocol for plasma B-EP determination.

Main Results:

• No significant difference in B-EP levels between AMI patients and controls, or in those with moderate pain.
• A significant drop in B-EP was observed in AMI patients with severe pain (p < 0.025).
• Significant negative correlations found between B-EP and chest pain intensity, LDH, AST, CPK, and cortisol levels.

Conclusions:

• Plasma B-EP levels decrease significantly with increasing pain severity in AMI.
• B-EP shows a negative correlation with key cardiac enzymes and cortisol, suggesting a role in the stress response during AMI.
• Further research is warranted to explore B-EP's therapeutic potential in managing AMI-related pain.